Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;25(7):680-682.
doi: 10.1111/resp.13852. Epub 2020 May 20.

The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times

Martyn A French  1   2 , Yuben Moodley  3   4   5
Affiliations
Comment

The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times

Martyn A French et al. Respirology. 2020 Jul.
No abstract available

Keywords: COVID-19; antibodies; immunopathology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are generally neutralizing and the virus is eliminated. However, the antibody response can enhance the inflammatory response through antibody‐dependent enhancement (ADE).
See this image and copyright information in PMC

Comment on

References

    1. Giamarellos‐Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami M‐E, Katsaounou P et al. Complex immune dysregulation in COVID‐19 patients with severe respiratory failure. Cell Host Microbe 2020; 27: 1–9. - PMC - PubMed
    1. French MA, Tjiam MC, Abudulai LN, Fernandez S. Antiviral functions of human immunodeficiency virus type 1 (HIV‐1)‐specific IgG antibodies: effects of antiretroviral therapy and implications for therapeutic HIV‐1 vaccine design. Front. Immunol. 2017; 8: 780. - PMC - PubMed
    1. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID‐19). Clin. Infect. Dis. 2020: ciaa310. 10.1093/cid/ciaa310. - DOI - PMC - PubMed
    1. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J et al. Antibody responses to SARS‐CoV‐2 in patients of novel coronavirus disease 2019. Clin. Infect. Dis. 2020: ciaa344. 10.1093/cid/ciaa34. - DOI - PMC - PubMed
    1. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS‐CoV‐2: an observational cohort study. Lancet Infect. Dis. 2020; 20: 565–74. - PMC - PubMed